iron III hydroxide polymaltozat – Maltofer Syrup 10 mg10164601 ml 1616 tablets 1616 ml. chewable 30 pcs

$19.00

Description

Latin name

Maltofer

Release form

chewable tablets, white and brown colored flat form

Packing

10 pcs – blisters (3) – packs of cardboard.

Pharmacological action of

Maltofer contains iron in the form of a polymaltose complex of iron (III) hydroxide. This macromolecular complex is stable and does not release iron in the form of free ions in the gastrointestinal tract.

The structure of the Maltofer ® preparation is similar to the natural iron compound ferritin. Due to this similarity, iron (III) enters the intestine into the bloodstream by active transport.

Absorbed iron binds to ferritin and is stored in the body, mainly in the liver. Then, in the bone marrow, it is included in the composition of hemoglobin.

Iron, which is part of the polymaltose complex of iron hydroxide (III), does not have prooxidant properties, unlike simple salts of iron.

There is a correlation between the severity of iron deficiency and its absorption level (the greater the severity of iron deficiency, the better absorption). The most active process of absorption occurs in the duodenum and small intestine.

Maltofer ® does not cause staining of tooth enamel.

Indications

– Latent iron deficiency and clinically pronounced iron deficiency (iron deficiency anemia)

– Prevention of iron deficiency in women during pregnancy, breastfeeding, in the childbearing period, in children, incl. in adolescence, in adults (for example, vegetarians and the elderly).

Contraindications

– Iron overload (eg, hemosiderosis and hemochromatosis).

– Disruption of iron utilization (lead anemia, siderohrestical anemia).

– Non-iron deficiency anemia (hemolytic, megaloblastic, caused by a lack of vitamin B 12).

Use in pregnancy and lactation

In controlled trials in pregnant women after the first trimester of pregnancy, no adverse effects on the mother and fetus were noted.

There were no negative effects of the drug on the fetus during the first trimester of pregnancy.

Composition

1 tab.

iron (in the form of iron (III) polymaltosate hydroxide) 100 mg

Excipients:

dextrates,

macrogol 6000,

talcum peeled,

sodium cyclamate,

vanillin,

cocoa powder,

chocolate flavor,

microcrystalline cellulose.

Dosage and Administration

Inside.

Take with or immediately after a meal. The daily dose of the drug depends on the degree of iron deficiency.

The duration of treatment for clinically pronounced iron deficiency (iron deficiency anemia) is 3-5 months, until hemoglobin levels normalize.

After this, the drug should be continued in a dosage for the treatment of latent iron deficiency for a few more months, and for pregnant women, at least until delivery to restore iron stores.

The duration of treatment for latent iron deficiency is 1 “2 months.

In the case of clinically severe iron deficiency, normalization of hemoglobin level and replenishment of iron stores occurs only 2-3 months after the start of treatment.

Side effects of the

From the digestive tract: sensation of overflow, pressure in the epigastric region, nausea, constipation or diarrhea, dark staining of the stool is possible due to the release of non-absorbable iron, which has no clinical significance.

Overdose

In cases of overdose, no signs of intoxication or signs of excess iron intake have been described to date.

Storage conditions

In a dark place at a temperature not exceeding 25 ° C.

Shelf life

5 years.

Deystvuyushtee substance

irons III gidroksid polimalytozat

Conditions of dispatch from

pharmacies Prescription from pfroaf4 pfroaf4 from

pharmacies Prescription

ma

lozenges

Possible product names

MALTOPHER 0.1 N30 CHEESDER

Maltofer 100 mg No. 30 w / tab

Maltofer 100mg Tab. chewing X30 (R)

Maltofer 100mg No. 30 tab

MALTOPER 100MG. No. 30 TAB.ZHEV.

Viefor (International) Inc., Switzerland